PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 186 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $73,050,120 | -13.7% | 1,892,000 | +18.8% | 1.27% | -13.3% |
| Q3 2022 | $84,678,000 | +145.3% | 1,592,000 | +168.9% | 1.47% | +144.0% |
| Q2 2022 | $34,514,000 | -13.7% | 592,000 | +13.0% | 0.60% | -22.1% |
| Q1 2022 | $39,992,000 | -49.3% | 524,000 | -60.1% | 0.77% | -40.2% |
| Q4 2021 | $78,943,000 | +50.6% | 1,312,000 | +40.2% | 1.29% | +45.5% |
| Q3 2021 | $52,416,000 | +28.5% | 936,000 | -12.7% | 0.89% | -60.2% |
| Q1 2019 | $40,800,000 | +80.2% | 1,072,000 | +47.5% | 2.23% | +29.0% |
| Q1 2018 | $22,636,000 | +51.2% | 726,671 | +121.5% | 1.73% | +15.9% |
| Q4 2017 | $14,973,000 | +38.5% | 328,000 | +13.9% | 1.49% | +17.2% |
| Q3 2017 | $10,814,000 | -16.3% | 288,000 | -28.0% | 1.27% | -58.3% |
| Q4 2016 | $12,920,000 | +40.9% | 400,000 | +49.3% | 3.06% | +3.8% |
| Q3 2016 | $9,171,000 | – | 268,000 | – | 2.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |